Detailed price information for Akebia Therapeutics (AKBA-Q) from The Globe and Mail including charting and trades.

Steroid replacement therapy is used for treating congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency in children and adults; we looked at the evidence for how well different regimens ...

HIF-prolyl hydroxylase inhibitor MK-8617 promotes renal tubule regeneration Jan. 27, 2025 ...

In the article that accompanies this editorial, the authors' trial results indicate that roxadustat, a proline hydroxylase inhibitor, was noninferior to erythropoiesis-stimulating agent therapy in ...

Scientists have found a potential treatment strategy for an aggressive type of leukemia by targeting enzymes used by cells to sense and adapt to oxygen levels. In findings published in Nature Cancer, ...

Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine (“InSilico”), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal ...

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...

The possibility that hypoxia signaling pathways exert control over immunity by actions on regulatory T lymphocytes is of great interest given that immune inflammatory pathology is often associated ...

Our editorial process produces two outputs: i) public reviews designed to be posted alongside the preprint for the benefit of readers; ii) feedback on the manuscript for the authors, including ...

The review analyzes the potential advantages and problems associated with using HIF prolyl hydroxylase inhibitors as a treatment for COVID-19. HIF prolyl hydroxylase inhibitors are known to boost ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. On February 12, the FDA accepted its first new drug ...